<DOC>
	<DOCNO>NCT01217086</DOCNO>
	<brief_summary>This trial see product similar remicade compare result blood sample co-administered methotrexate 12.5 25 mg/week , oral parenteral dose folic acid rheumatoid arthritis patient receive adequate response methotrexate alone week 30 .</brief_summary>
	<brief_title>Program evaLuating Autoimmune Disease iNvEstigational Drug cT-p13 RA Patients ( PLANETRA )</brief_title>
	<detailed_description />
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Infliximab</mesh_term>
	<criteria>diagnose active rheumatoid arthritis least 3 month treatment methotrexate allergy infliximab serious infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2013</verification_date>
</DOC>